Company Filing History:
Years Active: 1993-1996
Title: Fredericus A Asselbergs - Innovator in the Field of Pharmaceutical Compositions
Introduction: Fredericus A Asselbergs, a male inventor based in Riehen, Switzerland, has made significant contributions to the field of pharmaceutical compositions through his innovative patents.
Latest Patents:
1. Hybrid Plasminogen Activator: Asselbergs' latest patent involves novel single-chain hybrid plasminogen activators with modified N-glycosylation sites, exhibiting valuable pharmacological properties. These activators are produced using recombinant DNA technology.
2. Pharmaceutical Compositions: Asselbergs' invention focuses on pharmaceutical compositions comprising a combination of two different plasminogen activators for the prophylaxis and therapy of thrombosis.
Career Highlights: Asselbergs is associated with Ciba-Geigy Corporation, a renowned company in the pharmaceutical industry, where he continues to drive innovation through his research and patent filings.
Collaborations: Asselbergs has collaborated with esteemed coworkers such as Jutta Heim and Bhanu Rajput, further enriching the depth of his research and inventions in the field.
Conclusion: Fredericus A Asselbergs' dedication to developing novel pharmaceutical compositions underscores his commitment to advancing the field of medicine. His patents reflect a deep understanding of molecular biology and a relentless pursuit of innovation in healthcare.